In the latest quarter, 4 analysts provided ratings for Omnicell (NASDAQ:OMCL), showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below ...

Healthcare tech company Omnicell (NASDAQ:OMCL) will be reporting results tomorrow morning. Here’s what to expect. Omnicell beat analysts’ revenue expectations by 0.6% last quarter, reporting ...

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the fourth quarter ...

Get prepared with the key expectations. Enovis, Omnicell and Phreesia have been highlighted in this Industry Outlook article. Zacks Medical Info Systems industry stocks like Enovis, Omnicell and ...

Omnicell OMCL is advancing toward the industry-defined vision of Autonomous Pharmacy by leveraging automation and advanced services across its cloud-based platform. The strength of the company’s ...

Analyst Allen Lutz of Bank of America Securities maintained a Hold rating on Omnicell (OMCL – Research Report), retaining the price target of $46.00. Allen Lutz has given his Hold rating due to ...